Early fate decisions are dictated by the embryonic signaling environment. We show that Notch signaling is active during early mouse development and that activating Notch in human cardiac mesoderm enhances cardiomyocyte differentiation efficiency.
Introduction
An anatomically and functionally normal heart is the result of a coordinated series of specification events and cell movements that begin as early as gastrulation (Meilhac et al., 2014; Vincent and Buckingham, 2010) . Fate mapping of the early mouse embryo revealed the organized manner in which cells of the epiblast migrate through the primitive streak (PS) to become members of the separate germ layers (Lawson et al., 1991) . The consistency of these movements strongly suggests that the location and timing of ingression through the PS are determinants of cell fate. Notably, the earliest cells to ingress migrate across the embryo to become anterior structures, with those that do so later taking up more posterior positions (Lawson et al., 1991) . This pattern is consistent in zebrafish, with the first cells to gastrulate migrating to the future heart region ahead of those that ingress later (Keegan, 2004) . A series of experiments in avian embryos support the findings from mice, which assigned the prospective cardiogenic region of the presumptive PS and further delineate the time sensitivity of gastrulation movements in chick heart development Inagaki et al., 1993) . Importantly, epiblast cells fated to contribute to the heart are not committed to the cardiac lineage until shortly after they ingress through the PS, suggesting that lineage commitment occurs after gastrulation (Inagaki et al., 1993; Tam et al., 1997; Yutzey and Bader, 1995) .
Recent studies using genetic lineage tracing approaches have greatly advanced our understanding of these earliest events during heart development. Studies using Mesp1-Cre lineage tracing have further solidified the mechanisms proposed from fate mapping data (Devine et al., 2014; Lescroart et al., 2014; Saga et al., 1999) .
Specifically, the first cells to express Mesp1 contribute to derivatives of the first heart field, primarily the left ventricle. As more cells express Mesp1 and become specified to the cardiac lineage, they contribute to the heart from the right ventricle, atria, and finally outflow tract .
Previous work from our lab revealed the presence of a population of cells that transiently expresses Foxa2 during gastrulation and gives rise specifically to ventricular cardiovascular cells of the heart, likely representing cells that ingress and express Mesp1 early (Bardot et al., 2017b) . The striking similarity between the mouse, zebrafish, and chick models suggest conservation of the regional organization and sequence of early events during heart morphogenesis. The tools developed in these studies enable us to understand the early steps of heart development with increased resolution, at the time when heart progenitors are becoming committed to the cardiac lineage.
While patterns of early migration are well established, the heterogeneity within the cardiac progenitor pool and the signaling environments to which early and late-specified cells are exposed
are not yet well defined. Recent work has dissected the transcriptional landscape within the Me-sp1-expressing cardiac progenitor pool (Lescroart et al., 2018; Scialdone et al., 2016) . These analyses showed that cardiac progenitors are largely homogenous through E7.25. Between E7.25 and E7.5, as cells progress along the differentiation trajectory, two groups can be identified reflecting the first and second heart field lineages (Lescroart et al., 2018) . What remains unclear is how exposure to different signaling environments affects the differentiation trajectories of these progenitor populations.
Here, we have isolated several distinct mesoderm and endoderm populations from the mid gastrulation mouse embryo and utilized comparative transcriptome analysis to identify key regulatory pathways characteristic of each subpopulation. Specifically, we identified Notch signaling as a pathway for in vivo cardiac mesoderm specification, and showed that transient induction of Notch signaling in human pluripotent stem cell (hP-SC)-derived mesoderm enhances cardiomyocyte differentiation. Cardiomyocytes from Notch-induced cultures were less mature than their control counterparts and lacked a clear atrial vs. ventricular identity. We show that the increase in cardiomyocyte generation is a mesoderm specific effect, likely through interaction with other pathways important for mesoderm specification. We further validated this hypothesis through the modulation of Notch and WNT signaling in hPSC differentiation to cardiomyocytes, demonstrating that Notch signaling activation is sufficient for commitment to the cardiac lineage and necessary for differentiation in the absence of WNT inhibition. These data help us to better understand the earliest steps during cardiac commitment and highlight the similarities between the mouse and human differentiation programs.
Results

Identification and characterization of distinct mesoderm subpopulations in the gastrulating mouse embryo
We have previously used lineage-tracing with Foxa2Cre to identify a cardiac progenitor population that gives rise selectively to the ventricles of the heart, but not the atria (Sup. Fig. 1a ) (Bardot et al., 2017b) . To label the ventricular lineage during embryonic development, we crossed Fox-a2Cre mice with ROSA26-mTmG reporter mice, which express membrane-tethered Tomato in cells unexposed to Cre, but express membrane-tethered GFP after Cre recombination. Foxa2 lineage-traced cells (mGFP+) can be identified within the migratory mesodermal wings shortly after ingressing through the primitive streak (Sup. Fig.   1b ), and later in the cardiogenic region below the head folds at the anterior side of the embryo (Sup. Fig. 1c ). Foxa2 lineage-traced cells are restricted to a subdomain of the cardiac crescent and localize to the ventricular regions of the heart at all stages examined (Sup. Fig. 1d at this stage, as these share the core cardiac mesoderm gene signature ( Fig. 1h ). Both vCMes and aCMes samples expressed genes known to be enriched in Mesp1+ cardiac progenitors ( Fig. 1i ) .
CMes-expressed genes vCMes aCMes HMes End
We have previously performed gene expression analysis on mouse embryonic stem cell-derived CMes populations representing the Foxa2+ and Foxa2-progeny in vitro (Bardot et al., 2017b) . PCA comparing the in vitro populations with their in vivo counterparts initially showed large differences between the two systems, with PC1 separating the two datasets (Sup. Fig. 3a ).
Analysis of additional components restored the biological lineage relationships observed previously.
Specifically, PC2 separated the mesoderm and endoderm populations, and PC3 isolated the cardiac mesoderm from non-cardiac lineages (Sup. Fig. 3c ). Examining the genes driving the variance for each PC reveals that characteristic marker genes for mesoderm, endoderm, or cardiac mesoderm account for the separation seen in PC2 and PC3 (Sup. Fig. 3d ).
To elucidate differences between the vC-Mes and aCMes populations we first performed differential gene expression analysis. We found 416 differentially expressed genes (FDR<5%, fold change>1.5), with 129 and 287 genes enriched in the vCMes and aCMes populations, respectively ( Fig. 2a ). We focused our analysis on signaling pathways since we hypothesize that the signaling environment at this stage of development will affect cell fate decisions. Of the top 200 most upand down-regulated genes, 26 have been shown to have signaling roles ( Fig. 2b ). Further analysis using KEGG pathway datasets revealed Notch signaling to be the only statistically enriched path-way within the vCMes population ( Fig. 2c ). This is consistent with our previous in vitro CMes gene expression data, illustrating the comparability of the in vivo and in vitro systems at similar stages of differentiation ( Fig. 2c ) (Bardot et al., 2017b) . In addition, active Notch signaling could be observed in E7.5 mouse embryos, as detected by whole mount immunofluorescence for the Notch Intracellular Domain (NICD) (Fig. 2d ). NICD+ nuclei are found within the PDGFRA+ mesoderm and can be seen in both the ventricular (Foxa2Cre:H2B-mCherry+) and atrial (Foxa2Cre:H2B-mCherry-) lineages.
Overall, these analyses show that Notch signaling is active within the cardiac mesoderm in vivo and suggest a temporal gradient in the induction of this pathway during CMes differentiation.
Activation of Notch signaling enhances cardiomyocyte differentiation from human pluripotent stem cells
We have identified Notch pathway genes as being differentially expressed in cardiac mesoderm populations in mice, suggesting a potential role during early differentiation. To dissect the role of Notch during cardiac mesoderm commitment and differentiation in a temporally-controlled manner, we turned to the well-established human pluripotent stem cell (hPSC) differentiation system. In this model, hPSCs are differentiated in the presence of signaling molecules that recapitulate the in vivo signaling environment (Kattman et al., 2011; Yang et al., 2008) . In doing so, cells are guided along a normal developmental trajectory first exiting pluripotency, being patterned into mesoderm and specified to cardiac mesoderm, becoming committed to the cardiac lineage, and finally differentiating into functional cardiomyocytes ( Fig. 3a ) (Calderon et al., 2016; Kattman et al., 2011; Lian et al., 2013; Yang et al., 2008) . To specifically manipulate Notch signaling during this process, we used an hPSC line that expresses a Notch intracellular domain-estrogen receptor (NICD-ER) fusion from the human ROSA26 locus (Ditadi et al., 2015) .
These cells ubiquitously express the NICD-ER protein, which can be activated through addition bona fide cardiomyocyte marker cardiac troponin T (cTNT) ( Fig. 3d , quantified in e). Furthermore, we showed that the differentiation kinetics are not significantly affected upon Notch induction, as the onset of cTNT expression occurs at the same time in control and 4OHT-treated cultures (Fig. 3f ).
To determine if Notch is required for cardiomyocyte differentiation under these conditions, we also differentiated cells in the presence of the gamma-secretase inhibitor DAPT, which blocks cleavage of the Notch receptor, thereby inhibiting endogenous signaling activity (Sup. Fig. 4a ) (Dovey et al., 2001; Morohashi et al., 2006) . Treatment with DAPT for the same 24h time periods had no effect on cardiomyocyte differentiation overall (Sup. Fig. 4b , c). To ensure that this observation was not due to the limited time of inhibition or leakiness of the NICD-ER construct, we performed additional inhibition experiments using a human induced PSC (hiPSC) line. We differentiated hiPSCs in the presence of DAPT from days 3-6, covering the key early mesoderm formation and specification events (Sup. Fig. 4d ). These experiments confirmed that inhibition of Notch signaling has no effect on cardiomyocyte differentiation efficiency overall (Sup. Fig. 4e , f) , and is consistent with recent reports showing no effect from DAPT treatment in standard differentiation conditions (Biermann et al., 2019) . This suggests that either Notch signaling is not required for cardiomyocyte differentiation, or that the culture conditions provide a signaling environment that is sufficient to generate cardiomyocytes in the absence of active Notch signaling.
Cardiomyocytes derived from Notch-induced cardiac mesoderm are developmentally immature Key signaling events during early differentiation have been shown to impact cardiomyocyte subtype specification, both in vivo and in vitro (Devalla et al., 2015; Hochgreb, 2003; Lee et al., 2017; Xavier-Neto et al., 1999) . As we identified the Notch pathway as being enriched in ventricular cardiac mesoderm, we hypothesized that activating Notch would increase ventricular cardiomyocyte specification. To assess how Notch activation in the CMes affects the phenotype of the differentiated cardiomyocytes, we FACS-puri- As Notch was enriched in vCMes in vivo, we analyzed whether Notch induction in hPSC-derived CMes biases differentiation toward chamber-specific fates. Expression of several well-established atrial and ventricular marker genes did not show a consistent trend, suggesting that Notch signaling does not act to induce a chamber-specific lineage specification mechanism at this early stage of development ( Fig. 4c, d) (Cyganek et al., 2018) . Interestingly, the expression of MYL2 (ML-C2v), a ventricular-specific gene expressed during late differentiation, is downregulated in cardiomyocytes from Notch-induced CMes cultures compared to control (Fig. 4c ). We confirmed reduced MLC2v expression at the protein level through immunofluorescence analyses and quantification by flow cytometry (Fig. 4e, f) . However, no difference was seen in IRX4 expression, the earliest expressed ventricular-specific transcription factor, suggesting that while ventricular differentiation is compromised, fate acquisition may be unchanged 4OHT from days 5-6 showed a small increase in EdU incorporation at day 6 and 7, but this increase diminished quickly thereafter (Sup. Fig. 5b ). We therefore conclude that proliferation is not the key mechanism by which enhanced Notch signaling increases cardiomyocyte differentiation efficiency.
An alternative hypothesis is that Notch induction causes conversion of non-cardiac progenitors to the cardiac lineage. Since little is known about the role of Notch signaling within gastrulation-stage populations, we sought to use the hPSC differentiation system to dissect the mechanism of its action on these cells. Mesoderm can be detected as early as day 4 of differentiation using the cell surface marker CD13, and CXCR4 is used to exclude endoderm from the analysis (Skelton et al., 2016) . We first asked whether Notch increases the commitment of mesoderm to the cardiomyocyte fate or whether it can also convert non-mesodermal cells to the cardiac lineage. We FACS purified mesoderm (CD13+CXCR4-) and non-mesoderm (CD13-) populations at day 4 and plated them as individual monolayers for continued differentiation.
At day 5, a subset was treated with 4OHT to induce Notch signaling from day 5-6, as done previously. At day 30 the cultures were analyzed via flow cytometry to quantify differentiation efficiency ( Fig. 5a ). Differentiation cultures at day 4 were composed of 60±4.7% mesoderm and 20±5% non-mesodermal cells (Fig. 5b) . Mesoderm differentiated in the absence of Notch induction yielded 30±2.5% cardiomyocytes at day 30 (Fig. 5c, left) .
However, when Notch was induced from day 5-6, the efficiency of differentiation was increased to 80±0.7% (Fig. 5c, right 5d ).
To confirm the mesoderm-specific effect seen in these experiments, we differentiated hP-
SCs into definitive endoderm progenitors, induced
Notch, and analyzed for the presence of cardiomyocytes to assess fate conversion (Sup. Fig.   6a ). Definitive endoderm was generated through the addition of high amounts of Activin A at days 1 and 4 of differentiation, and cells were treated with 4OHT from day 5-6, as in previous experiments.
This approach yields 49.5±23.6% definitive endoderm cells at day 5 of differentiation, as indicated by the expression of CXCR4 and cKIT (Sup. HMes (Fig. 5f ). CMes that was differentiated without Notch induction gave rise to 35.7±11.4% SIR-PA+CD90-cardiomyocytes, similar to the control CD13+CDCR4-day 4 mesoderm (Fig. 5g, left) .
Again, Notch induction increased this efficiency to 76±9.5% (Fig. 5g, right) . We also observed a statistically significant increase when differentiating HMes into cardiomyocytes in the presence of Notch signaling as compared to control, consistent with previous data from the mouse PSC system ( Fig. 5h) Fig. 6e ) (Devalla et al., 2015; Lee et al., 2017) . In addition to generating atrial-like cardiomyocytes, adding atRA also greatly increases the efficiency of differentiation (Sup. Fig. 6f, g) . We did not observe a further increase in cardiomyocyte differentiation efficiency upon Notch induction from day 5-6 (Sup. Fig. 6f, g) .
Notch induction is required for cardiomyocyte differentiation in the absence of WNT inhibition
Given that Notch signaling appears to act on mesoderm specifically, we sought to deter- Fig. 7a ). Culturing cells in the absence of VEGF throughout differentiation had no effect on overall cardiomyocyte generation efficiency, whether or not Notch was induced (Sup. Fig. 7b, c) . Immunofluorescence analysis for cTNT and alpha-actinin (aACT) confirmed that phenotypically normal cardiomyocytes were present in the absence of VEGF (Sup. Fig.   7d ), leading us to conclude that under these culture conditions VEGF has no effect on hPSC differentiation to cardiomyocytes.
However, cells differentiated without XAV939 yielded less than 8.5±4% cardiomyocytes at day 30, confirming that WNT inhibition is essential for commitment of cells to the cardiac lineage, as shown previously (Fig. 6a, b) (Lian et al., 2013) .
Addition of DAPT failed to enhance this effect (Fig.   6b ). Interestingly, induction of Notch from day 4-5 in the absence of XAV939 was able to restore cardiomyocyte differentiation to control levels (Fig.   6b ). This suggests that Notch is required for cardiomyocyte differentiation in the absence of WNT inhibition, and that Notch may be acting to inhibit WNT signaling during that process. To further examine that hypothesis, we cultured cells in the presence of the GSK3B inhibitor CHIR, which stabilizes B-catenin and results in constitutive activation of canonical WNT signaling. Addition of CHIR completely blocked cardiomyocyte differentiation, and Notch induction failed to rescue this effect ( Fig. 6b ). Quantification of these data confirm the interaction of Notch and WNT signaling in these experiments (Fig. 6c ). In all conditions where cardiomyocytes were detected by flow cytometry analysis, immunofluorescence analysis for cTNT and aACT confirmed the presence of phenotypically normal cardiomyocytes (Fig. 6d) . Overall, our data support a model in which Notch signaling acts to increase cardiac lineage commitment by inhibiting WNT activity and show that Notch signaling on its own is sufficient to commit mesoderm to the cardiac lineage.
Discussion
We have previously identified a ventricular-specific cardiac progenitor population specified during gastrulation through the use of Foxa2 lineage-tracing (Bardot et al., 2017b) . Here, we have expanded on these findings and studied the heterogeneity of cardiac mesoderm cell populations and the early steps of cardiac mesoderm differentiation both in vivo and in vitro. Our study focused on a developmental stage occurring at E7.25 in vivo or day 5 of hPSC differentiation, which is likely prior to lineage commitment. This stage encompasses the earliest steps of cardiac specification and captures the differential embryonic signaling environment cells are exposed to as they migrate anteriorly to form the cardiac crescent. Foxa2 lineage-tracing has enabled us to distinguish, at this early stage, the mesoderm populations that will give rise to ventricular cells (vCMes) versus atrial cells (aCMes) later during development, and therefore gives us the ability to investigate early versus late differentiating cells of the cardiovascular lineage.
The in vivo RNA-seq analysis we performed suggest that cardiac mesoderm from the mouse embryo and from mESCs are overall similar after accounting for technical differences. Notch signaling appears to be active in all cardiac mesoderm populations, though cells further along the differentiation trajectory in both systems (Foxa2-hCD4+
CMes in vitro, Foxa2Cre:YFP+ CMes in vivo) express higher levels of some Notch pathway components. Other studies have shown that Notch1 is expressed in early Mesp1+ cardiac precursors that are fated for the endothelial lineage, but did not address whether Notch signaling plays a role in that lineage decision (Lescroart et al., 2018) . We observed expression of Notch1-3 in both aCMes and vCMes, though we are unable to determine the relationship between receptor expression and lin-eage decision from our data. By taking advantage of the hPSC cardiomyocyte differentiation model, we were able to show that inducing Notch signaling in hPSC-derived cardiac mesoderm enhances cardiomyocyte differentiation overall. Such transient Notch induction appears not to affect atrial vs. ventricular fate decisions, but rather increases cardiomyocyte generation efficiency more generally. This suggests that while Notch components are enriched in ventricular-fated cardiac mesoderm, we likely capture a snapshot of development when Notch signaling is being consecutively activated in migratory mesoderm. While all cardiac mesoderm will be subjected to Notch signaling, the early differentiating ventricular progenitors receive the signal first, while later-specified atrial progenitors are exposed to it subsequently.
Within the heart, Notch is known to act at numerous stages during development in different organisms (High and Epstein, 2008) . Aberrant activation of Notch signaling in cardiac precursors causes an enlargement of the left ventricle and may negatively impact maturation of the forming cardiomyocytes (Watanabe, 2006) . While Notch activation in the cardiac lineage showed a hyperplasic phenotype, induction of Notch signaling in the epiblast has a negative overall impact on mesoderm specification and organization (Souilhol et al., 2015) . Data from Xenopus suggests that active Notch signaling is important during a brief time window between gastrulation and differentiation, and that this timing acts to coordinate progenitor maintenance and differentiation. Specifically, premature dampening of the Notch pathway results in cardiac progenitors upregulating the differentiation program prior to reaching the midline of the embryo (Miazga and McLaughlin, 2009 ). This is consistent with our data showing that transient Notch induction specifically at the cardiac mesoderm stage enhances cardiomyocyte differentiation ef-ficiency. We also showed that the inductive effects of Notch signaling are specific to mesoderm, and that Notch was insufficient to convert endoderm to the cardiac lineage.
Knowing that the differentiation protocol used provides a highly cardiogenic signaling environment, we sought to determine the interaction between Notch and other relevant pathways. Despite the expression of VEGFR2 (KDR) in both in vivo and in vitro mesoderm, removing VEGF had little effect on hPSC differentiation overall. This is consistent with data from the mouse embryo showing that while Kdr is required for the formation of hematopoietic lineages, it is not required for cardiac progenitor formation (Ema et al., 2006) . Notch is known to interact with other signaling pathways, particularly the BMP and Wnt pathways. Notch has been shown to activate the non-canonical Wnt5a ligand later during heart development, further suggesting a link between these two pathways . It was previously shown that mouse ESC-derived Kdr+ cells fated to the hematopoietic and vascular lineages can be redirected to the cardiac lineage via Notch activation (Chen et al., 2008) . Gene expression profiling revealed that this was in part due to upregulation of BMP pathway genes and downregulation of canonical Wnt signaling, ultimately mimicking the signaling cocktail used to generate cardiomyocytes from PSCs. In the embryo, the overlying endoderm provides high levels of Wnt-inhibitory proteins to the developing mesoderm, and proper endoderm development has been shown to be critical for heart development (Marvin et al., 2001; Nascone and Mercola, 1995; Schneider and Mercola, 2001; Schultheiss et al., 1995) .
In accordance with an important role for Wnt inhibition during cardiac mesoderm specification, our analysis reveals expression of secreted Wnt inhibitory proteins and non-canonical ligands, with Sfrp1 being enriched in early-migrating ventricular cardiac mesoderm (Figure 2b) . Consistent with the importance of that interaction, we found that failing to inhibit WNT in vitro almost completely eliminated cardiomyocyte differentiation. Interestingly, Notch induction is sufficient to rescue hPSC differentiation to control levels, providing evidence that these two pathways interact during cardiac mesoderm commitment. We therefore believe that Notch in the cardiac mesoderm is acting in concert with the overlying endoderm to establish a Wnt-inhibitory zone as cells approach the anterior side of the embryo, and that inducing Notch during hPSC differentiation recapitulates aspects of this mechanism. These findings have implications for therapeutic uses, as a fuller understanding of the in vivo signaling environment may lead to development of cardiomyocyte differentiation protocols with improved efficiency and cardiomyocyte subtype selectivity.
Our experiments illustrating enhanced cardiomyocyte differentiation after Notch induction nicely corroborate our gene expression profiling in vivo and suggest that Notch plays a role during early mammalian heart development, a stage that is technically challenging to manipulate in a temporally and spatially controlled manner. Going forward, it will be important to dissect the detailed mechanism for how this occurs, and whether Notch signaling in the cardiac mesoderm is broadly cardiogenic. While studies have looked at the effects of Notch signaling on mouse development, these have largely been done using constitutive Notch activation (Souilhol et al., 2015; Watanabe, 2006) . It would be of great interest to perturb Notch signaling within the early cardiac lineage in a temporally controlled and reversible manner, as has been done in other model organisms (Miazga and McLaughlin, 2009 ).
In summary, we have used a combination of mouse embryo and human PSC approaches to dissect the early steps of heart progenitor specification. By performing whole transcriptome analysis on in vivo cardiac mesoderm, we identified an enrichment for Notch pathway components in the early-differentiating ventricular lineage. Using human pluripotent stem cell directed differentiations, we found that transient Notch induction at the cardiac mesoderm stage increases the efficiency of cardiomyocyte differentiation. Surprisingly, Notch activation does not impact the proportion of ventricular cardiomyocytes formed, but rather yields cells less developmentally mature than control counterparts. Finally, we show that the cardiac-inducing effect of Notch signaling is restricted to mesodermal cells and may act to inhibit Wnt signaling. These data reveal a role for Notch signaling in committing early mesoderm to the cardiac lineage in both mouse and human systems.
Materials and methods
Mice
The Foxa2Cre mouse line (C57BL/6J) was generated and shared with us by Dr. Heiko Lickert (Horn et al., 2012) . Rosa26-YFP (006148; C57BL/6J), 
Cell lines
The ROSA26:NICD-ER hESC line was generated and generously shared with us by Dr. Paul Gadue (Ditadi et al., 2015; Gadue et al., 2006) . The
MYL2-mEGFP WT hiPSC line was obtained from
the Coriell Institute (Line no. AICS-0060-027).
Histology and Immunofluorescence
Embryos were collected from timed pregnancies and either fixed in 4% PFA, washed with phosphate buffered saline (PBS) and equilibrated in anti-GFP (abcam, 1:500); anti-RFP (Rockland, 1:500); anti-cTnT (ThermoSci, 1:300); anti-Mlc2v (Proteintech, 1:100). Secondary antibodies conjugated with Alexa dyes were obtained from Jackson Immunoresearch and used at 1:500.
Fluorescence images were obtained using either Leica DM6000 or DM5500B microscopes. Confocal microscopy was performed using a Zeiss 780 microscope. Images were processed using Imaris 8, FIJI ImageJ, or Adobe Photoshop software (Bardot et al., 2017a) .
Human pluripotent stem cell differentiations
Mesoderm/Cardiac: Embryoid bodies (EBs) were generated from ESC lines using collagenase B (Roche) and cultured in RPMI 1640 base media (ThermoFisher) containing 0.5X B27 supplement (ThermoFisher), 2mM glutamine (Gibco-BRL), 1 mM ascorbic acid (Sigma), and 4x10−4 M monothioglycerol (Sigma)) with BMP4 (1 ng/ml, R&Dsystem) and Thiazovivin (2 μM, Millipore). On day 1, EBs were harvested and resuspended in induction medium (base media with basic fibroblast growth factor (bFGF; 2.5 ng/ml, R&Dsystem), activin A (20 ng/ml, R&Dsystem) and BMP4 (20 ng/ ml)). On day 3, the EBs were harvested and resuspended in base media with vascular endothelial growth factor (VEGF; 10 ng/ml, R&Dsystem) and XAV939 (10 μM, Stemolecule). On day 3, the EBs were harvested and resuspended in base media with vascular endothelial growth factor (VEGF; 10 ng/ml, R&Dsystem). On day 8 and thereafter, EBs were cultured in base media until day 30 for further analysis.
Endoderm: Human pluripotent stem cells were differentiated into the endoderm lineage as previously described (Goldman et al., 2013) . Briefly, cells were dissociated using collagenase B (Roche) and cultured in low cluster plates to allow EB formation in in RPMI 1640 base media (ThermoFisher) supplemented with BMP4 (3 ng/ml, R&D Systems) and Thiazovivin (2 μM, Millipore). At day 1 the medium was changed to base media supplemented with Activin A (100 ng/ml, R&D Systems), basic FGF (bFGF, 2.5 ng/ml, R&D Systems), and BMP4 (0.5 ng/ml, R&D Systems). At day 4, the medium was changed to the base media supplemented with Activin A (100 ng/ml), bFGF (2.5 ng/ml), and vascular endothelial growth factor (VEGF, 10 ng/ ml, R&D Systems). On day 5 EBs were dissociated and analyzed for CXCR4+ cKIT+ cells. On day 6 and thereafter, EBs were cultured in base media until day 30 for further analysis.
Isolation and differentiation of early subpopulations during differentiation
On day 4 of cardiac differentiation, EBs were dissociated using TrypLE (Invitrogen). CXCR4-CD13+ and CXCR4-CD13+ cells were sorted and cultured in matrigel-coated 96 well plates at 1 × 105 cells per well in base media with vascular endothelial growth factor (VEGF; 10 ng/ml), XAV939 (10microM), and Thiazovivin (2 μM). On day 5, the media was changed to base media with vascular endothelial growth factor (VEGF; 10 ng/ml), and cultures were maintained in this media until day 8 of differentiation, when cells were cultured in base media only, with media changes every 3 days until day 30, when cells were analyzed.
On day 5 of cardiac differentiation, EBs were dissociated using TrypLE (Invitrogen). PDGFRA+K-DR+, PDGFRA-KDR+ and PDGFRA-KDR-cells were sorted and cultured in matrigel-coated 96 well plates at 1x105 cells per well in base media with vascular endothelial growth factor (VEGF; 10 ng/ml) and Thiazovivin (2 μM). On day 6, the media was changed to base media with vascular endothelial growth factor (VEGF; 10 ng/ml), and cultures were maintained in this media until day 8 of differentiation, when cells were cultured in base media only, with media changes every 3 days until day 30, when cells were analyzed. 
Flow cytometry analysis and cell sorting
RNA-seq data processing
Quality analysis of raw sequencing reads was performed using FastQC (http://www.bioinformatics. bbsrc.ac.uk/projects/fastqc/). Reads were then aligned to the mouse reference genome (mm10) for mouse samples or the human reference genome (hg19) for human samples using STAR with the two-pass setting (Dobin et al., 2013) , and a database of known splice junctions from the EN-CODE mm10/GRCm38 annotation for the initial alignment (http://www.gencodegenes.org/mouse_ releases/2.html). Picard tools (http://broadinstitute.github.io/picard/) was used to index and re-move duplicate reads from the resulting SAM files, generating 16-25 million unique aligned reads per sample. From the resulting alignments, we used HTSeq (Anders et al., 2015) to generate read counts per transcript, and normalized these and performed differential expression analysis using DESeq2 (Love et al., 2014) . Gene ontology analysis was performed using Panther GO (http://geneontology.org/page/go-enrichment-analysis). All heatmaps were generated using the R package pheatmap (v 1.0.8). PCA and MA plots were generated using the R packages ggplot2 (v 2.0.0) and
DESeq2 (v 1.10.1). The developmental benchmarking was performed using the R package princomp on Log10 FPKM data, as previously described (DeLaughter et al., 2016) .
Statistical analysis
Statistical analysis was performed using Student's t-test and is presented as statistically significant (*) with a p-value cutoff of p < 0.05. Unless specified, error bars indicate mean ± standard deviation. 
